Esperion Therapeutics, Inc. (ESPR)
2.335
-0.22
(-8.43%)
USD |
NASDAQ |
Apr 07, 10:31
Esperion Therapeutics SG&A Expense (TTM) : 165.79M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Nektar Therapeutics | 68.67M |
| Harrow, Inc. | 152.91M |
| Catalyst Pharmaceuticals, Inc. | 171.18M |
| Regeneron Pharmaceuticals, Inc. | 2.70B |
| Rigel Pharmaceuticals, Inc. | 115.90M |